Version française
Institutes/ Institute of biomedical imaging (I²BM)/ Disease Imaging, Neuroscience and Applications Centre (Ci-NAPS (B. Mazoyer))/ Publications

Publications  - 2009

  1. Anglés-Cano E, Vivien D, Strokavenir (2009). Cellular microparticles, potential useful biomarkers in the identification of cerebrovascular accidents] Med Sci (Paris). 25(10): 843-846
  2. Bardou I, Maubert E, Leprince J, Chichery R, Cocquerelle C, Launay S, Vivien D, Vaudry H, Agin V (2009). Distribution of oxytocin-like and vasopressin-like immunoreactivities within the central nervous system of the cuttlefish, Sepia officinalis. Cell Tissue Res. 336: 249-266
  3. Baron A, Montagne A, Cassé F, Launay S, Maubert E, Ali C, Vivien D (2009). NR2D-containing NMDA receptors mediate tissue plasminogen activator-promoted neuronal excitotoxicity. Cell Death Differ. In press
  4. Bihel E, Pro-Sistiaga P, Letourneur A, Toutain J, Saulnier R, Insausti R, Bernaudin M, Roussel S, Touzani O (2009). Permanent or transient chronic ischemic stroke in the non-human primate: behavioral, neuroimaging, histological, and immunohistochemical investigations. J Cereb Blood Flow Metab. In press
  5. Borha A, Parienti J, Emery E, Coskun O, Khouri S, Derlon J (2009). Candida albicans cerebral granuloma in an immunocompetent patient. A case report. Neurochirurgie 55: 57-62
  6. Bouet V, Boulouard M, Toutain J, Divoux D, Bernaudin M, Schumann-Bard P, Freret T (2009). The adhesive removal test: a sensitive method to assess sensorimotor deficits in mice. Nat Protoc. 4: 1560-1564
  7. Buyck JF, Dufouil C, Mazoyer B, Maillard P, Ducimetière P, Alpérovitch A, Bousser MG, Kurth T, Tzourio C (2009). Cerebral White Matter Lesions Are Associated With the Risk of Stroke But Not With Other Vascular Events. The 3-City Dijon Study. Stroke 40(7): 2327-2331
  8. Cassotti M, Moutier S (2009). How to explain receptivity to conjunction-fallacy inhibition training: Evidence from the Iowa Gambling Task. Brain & Cognition. In press
  9. Correa F, Docagne F, Mestre L, Clemente D, Hernangómez M, Loría F, Guaza C (2009). A role for CB2 receptors in anandamide signalling pathways involved in the regulation of IL-12 and IL-23 in microglial cells. Biochem Pharmacol. 77: 86-100
  10. Culot M, Mysiorek C, Renftel M, Roussel B, Hommet Y, Vivien D, Cecchelli R, Fenart L, Berezowski V, Dehouck M, Lundquist S (2009). Cerebrovascular protection as a possible mechanism for the protective effects of NXY-059 in preclinical models: An in vitro study. Brain Res. 1294: 144-152
  11. Cunningham O, Campion S, Perry V, Sidenius N, Docagne F, Cunningham C (2009). Microglia and the urokinase plasminogen activator receptor 1 (uPAR) / uPA system in innate brain inflammation. Glia 57: 1802-1814
  12. Daoud H, Gruchy N, Constans J, Moussaoui E, Saumureau S, Bayou N, Amy M, Védrine S, Vu P, Rötig A, Laumonnier F, Vourc'h P, Andres C, Leporrier N, Briault S (2009). Haploinsufficiency of the GPD2 gene in a patient with nonsyndromic mental retardation. Hum Genet 124: 649-658
  13. David HN, Haelewyn B, Chazalviel L, Lecocq M, Degoulet M, Risso JJ, Abraini JH (2009). Post-ischemic helium provides neuroprotection in rats subjected to middle cerebral artery occlusion-induced ischemia by producing hypothermia. J Cereb Blood Flow Metab. 29: 1159-1165
  14. Davidson M, Galderisi S, Weiser M, Werbeloff N, Fleischhacker W, Keefe R, Boter H, Keet I, Prelipceanu D, Rybakowski J, Libiger J, Hummer M, Dollfus S, López-Ibor J, Hranov L, Gaebel W, Peuskens J, Lindefors N, Riecher-Rössler A, Kahn R (2009). Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial EUFEST. Am J Psychiatry 166: 675-682
  15. Degoulet MF, Rostain JC, David HN, Abraini JH (2009). Repeated administration of amphetamine induces a shift of the prefrontal cortex and basolateral amygdala motor function. Int J Neuropsychopharmacol. 23:1-10
  16. Delamillieure P, Doucet G, Mazoyer B, Turbelin MR, Delcroix N,  Mellet E, Zago L, Crivello F, Petit L, Tzourio-Mazoyer N, Joliot M (2009). ReSQ: an introspective questionnaire for evaluation of inner experience during the conscious resting state. Brain Res. Bull. In press
  17. Doeuvre L, Angles-Cano E (2009). Cell-derived microparticles unveil their fibrinolytic and proteolytic function. Med Sci. 25: 37-44
  18. Doeuvre L, Plawinski L, Toti F, Anglés-Cano E (2009). Cell-derived microparticles: a new challenge in neuroscience. J Neurochem. 110: 457-468
  19. Dufouil C, Godin O, Chalmers J, Coskun O, MacMahon S, Tzourio-Mazoyer N, Bousser MG, Anderson C, Mazoyer B, Tzourio (2009). Severe cerebral white matter hyperintensities predict severe cognitive decline in patients with cerebrovascular disease history. C.PROGRESS MRI Substudy Investigators. Stroke 40: 2219-2221
  20. Duval C, Desgranges B, Eustache F, Piolino P (2009). Looking at the self under the microscope of cognitive neurosciences: from self-consciousness to consciousness of others. Psychol Neuropsychiatr Vieil. 7: 7-19
  21. Foucout L, Gourand F, Dhilly M, Bohn P, Dupas G, Costentin J, Abbas A, Marsais F, Barré L, Levacher V (2009). Synthesis, radiosynthesis and biological evaluation of 1,4-dihydroquinoline derivatives as new carriers for specific brain delivery. Org Biomol Chem. 7(18): 3666-3673
  22. Fouquet M, Desgranges B, Landeau B, Duchesnay E, Mazenge F, de la Sayette V, Viader F, Baron JC, Eustache F, Châtelat G (2009). Longitudinal brain metabolic changes from amnestic Mild Cognitive Impairment to Alzheimer's Disease. Brain 132: 2058-2067
  23. Freret T, Bouet V, Leconte C, Roussel S, Chazalviel L, Divoux D, Schumann-Bard P, Boulouard M (2009). Behavioural deficits after distal focal cerebral ischemia in mice: usefulness of the adhesive removal test. Behav Neurosci. 123: 224-230
  24. Galderisi S, Davidson M, Kahn RS, Mucci A, Boter H, Gheorghe MD, Rybakowski JK, Libiger J, Dollfus S, López-Ibor JJ, Peuskens J, Hranov LG, Fleischhacker WW, EUFEST group (2009). Correlates of cognitive impairment in first episode schizophrenia: the EUFEST study. Schizophr Res.115(2-3): 104-114
  25. Garcia-Ovejero D, Arevalo-Martin A, Petrosino S, Docagne F, Hagen C, Bisogno T, Watanabe M, Guaza C, Di Marzo V, Molina-Holgado E (2009). The endocannabinoid system is modulated in response to spinal cord injury in rats. Neurobiol Dis. 33: 57-71
  26. Godin O, Maillard P, Crivello F, Alpérovitch A, Mazoyer B, Tzourio C, Dufouil C (2009). Association of white-matter lesions with brain atrophy markers: the three-city Dijon MRI study. Cerebrovasc Dis. 28(2): 177-184
  27. Godin O, Tzourio C, Maillard P, Alpérovitch A, Mazoyer B, Dufouil C (2009). Apolipoprotein E genotype is related to progression of white matter lesion load. Stroke 40(10): 3186-3190
  28. Gouix E, Léveillé F, Nicole O, Melon C, Had-Aissouni L, Buisson A (2009). Reverse glial glutamate uptake triggers neuronal cell death through extrasynaptic NMDA receptor activation. Mol Cell Neurosci. 40: 463-473
  29. Guillamo J, de Boüard S, Valable S, Marteau L, Leuraud P, Marie Y, Poupon M, Parienti J, Raymond E, Peschanski M (2009). Molecular Mechanisms Underlying Effects of Epidermal Growth Factor Receptor Inhibition on Invasion, Proliferation, and Angiogenesis in Experimental Glioma. Clin Cancer Res. 15: 3697-3704
  30. Ho-Tin-Noé B, Enslen H, Doeuvre L, Corsi J, Lijnen H, Anglés-Cano E (2009). Role of plasminogen activation in neuronal organization and survival. Mol Cell Neurosci. 42(4): 288-295
  31. Houdé O (2009). Abstract after all? Abstraction through inhibition in children and adults.Behav. Brain Sci. 32(3-4): 339-3340 ; discussion 356-373
  32. Houdé O, Rossi S, Lubin A, Joliot M (2009). Mapping numeracy, reading, and executive functions in the developing brain: An fMRI meta-analysis on 52 studies and 842 children. Dev Sci. 12: 328-336
  33. Joliot M, Leroux G, Dubal S, Tzourio-Mazoyer N, Houdé O, Mazoyer B, Petit L (2009). Cognitive inhibition of number/length interference in a Piaget-like task: evidence by combining ERP and MEG. Clin Neurophysiol. 120(8): 1501-1513
  34. Kalpouzos G, Chételat G, Baron J, Landeau B, Mevel K, Godeau C, Barré L, Constans J, Viader F, Eustache F, Desgranges B (2009). Voxel based mapping of brain gray matter volume and glucose metabolism profiles in normal aging. Neurobiol Aging 30: 112-124
  35. Laisney M, Matuszewski V, Mézenge F, Belliard S, de la Sayette V, Eustache F, Desgranges B (2009). The underlying mechanisms of verbal fluency deficit in frontotemporal dementia and semantic dementia. J Neurol. 256: 1083-1094
  36. Lecardeur L, Briand C, Prouteau A, Lalonde P, Nicole L, Lesage A, Stip E (2009). Preserved awareness of their cognitive deficits in patients with schizophrenia: convergent validity of the SSTICS. Schizophrenia Research 107: 303-306
  37. Leconte C, Tixier E, Freret T, Toutain J, Saulnier R, Boulouard M, Roussel S, Schumann-Bard P, Bernaudin M (2009). Delayed Hypoxic Postconditioning Protects Against Cerebral Ischemia in the Mouse. Stroke 40: 3349-3355
  38. Lefèvre G, Babchia N, Calipel A, Mouriaux F, Faussat A, Mrzyk S, Mascarelli F (2009). Activation of the FGF2/FGFR1 autocrine loop for cell proliferation and survival in uveal melanoma cells. Invest Ophthalmol Vis Sci.  50: 1047-1057
  39. Legros H, Launay S, Roussel BD, Marcou-Labarre A, Calbo S, Catteau J, Leroux P, Boyer O, Ali C, Marret S, Vivien D, Laudenbach V (2009). Newborn- and adult-derived brain microvascular endothelial cells show age-related differences in phenotype and glutamate-evoked protease release. J Cereb Blood Flow Metab. 29(6): 1146-1158
  40. Leroux G, Spiess J, Zago L, Rossi S, Lubin A, Turbelin MR, Mazoyer B, Tzourio-Mazoyer N, Houdé O, Joliot M (2009). Adult brains don't fully overcome biases that lead to incorrect performance during cognitive development: an fMRI study in young adults completing a Piaget-like task. Dev Sci. 12: 326-338
  41. Lescot E, Sopkova-de Oliveira Santos J, Colloc'h N, Rodrigo J, Milazzo-Segalas I, Bureau R, Rault S (2009). Three-dimensional model of the human urotensin-II receptor: docking of human urotensin-II and nonpeptide antagonists in the binding site and comparison with an antagonist pharmacophore model. Proteins 73: 173-184
  42. Lubin A, Poirel N, Rossi S, Lanoé C, Pineau A, Houdé O (2009). Pedagogical effect of action on arithmetic performances in Wynn-like tasks solved by 2-year-olds. Exp Psychol. In press
  43. Lubin A, Poirel N, Rossi S, Pineau A, Houdé O (2009). Math in actions: Actor mode reveals the true arithmetic abilities of French-speaking 2-year-olds in a magic task. J Exp Child Psychol. 103(3): 376-385
  44. Maillard P, Crivello F, Dufouil C, Tzourio-Mazoyer N, Tzourio C, Mazoyer B (2009). Longitudinal follow-up of individual white matter hyperintensities in a large cohort of elderly. Neuroradiology 51: 209-220
  45. Matuszewski V, Piolino P, Belliard S, de la Sayette V, Laisney M, Lalevée C, Pélerin A, Viader F, Eustache F, Desgranges B (2009). Patterns of autobiographical memory impairment according to disease severity in semantic dementia. Cortex 45: 456-472
  46. Mazoyer B, Houdé O, Joliot M, Mellet E, Tzourio-Mazoyer N (2009). Regional cerebral blood flow increases during wakeful rest following cognitive training. Brain Res Bull. 80(3): 133-138
  47. Mellet E, Laou L, Petit L, Zago L, Mazoyer B, Tzourio-Mazoyer N (2009). Impact of the virtual reality on the neural representation of an environment. Human Brain Mapping. In press
  48. Mestre L, Docagne F, Correa F, Loría F, Hernangómez M, Borrell J, Guaza C (2009). A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by downregulating adhesion molecules. Mol Cell Neurosci. 40: 258-266
  49. Moldrich R, Dauphinot L, Laffaire J, Vitalis T, Hérault Y, Beart P, RossierJ, Vivien D, Gehrig C, Antonarakis S, Lyle R, Potier M (2009). Proliferation deficits and gene expression dysregulation in Down's syndrome (Ts1Cje) neural progenitor cells cultured from neurospheres. J Neurosci Res. 87: 3143-3152
  50. Montagne-Larmurier A, Etard O, Razafimandimby A, Morello R, Dollfus S (2009). Two-day treatment of auditory hallucinations by high frequency rTMS guided by cerebral imaging: a 6 month follow-up pilot study. Schizophr Res. 113(1): 77-83
  51. Petit L, Zago L, Vigneau M, Andersson F, Crivello F, Mazoyer B, Mellet E, Tzourio-Mazoyer N (2009). Functional asymmetries revealed in visually guided saccades: an FMRI study. J Neurophysiol. 102(5): 2994-3003
  52. Poisnel G, Dhilly M, Boisselier RL, Barre L, Debruyne D (2009). Comparison of five benzodiazepine-receptor agonists on buprenorphine-induced mu-opioid receptor regulation. J Pharmacol Sci. 110: 36-46
  53. Roussel BD, Macrez R, Jullienne A, Agin V, Maubert E, Dauphinot L, Potier MC, Plawinski L, Castel H, Hommet Y, Munuera J, Montaner J, Yepes M, Ali C, Vivien D (2009). Age and albumin D site-binding protein control tissue plasminogen activator levels: neurotoxic impact. Brain 132: 2219-2230
  54. Roussel BD, Macrez R, Jullienne A, Agin V, Maubert E, Dauphinot L, Potier MC, Plawinski L, Castel H, Hommet Y, Munuera J, Montaner J, Yepes M, Ali C, Vivien D (2009). Age and albumin D site-binding protein control tissue plasminogen activator levels: neurotoxic impact. Brain. 132(Pt 8): 2219-2230
  55. Sobrio F, Lemaitre S, Hinsberger A, Barré L, Rousseau B, Rault S (2009). Simultaneous tritium labelling of two potent 5-HT(4) ligands. Eur J Med Chem. In press
  56. Soumaré A, Elbaz A, Zhu Y, Maillard P, Crivello F, Tavernier B, Dufouil C, Mazoyer B, Tzourio C (2009). White matter lesions volume and motor performances in the elderly. Ann Neurol. 65(6): 706-715
  57. Stip E, Mancini-Marïe A, Letourneau G, Fahim C, Mensour B, Crivello F, Dollfus S (2009). Increased grey matter densities in schizophrenia patients with negative symptoms after treatment with quetiapine: a voxel-based morphometry study. Int Clin Psychopharmacol. 24: 34-41
  58. Tzourio-Mazoyer N, Simon G, Crivello F, Jobard G, Zago L, Perchey G, Hervé PY, Joliot M, Petit L, Mellet E, Mazoyer B (2009). Effects of Familial Sinistrality on Planum Temporale Surface and Brain Tissue Asymmetries. Cereb Cortex. In press
  59. Valable S, Eddi D, Constans JM, Guillamo JS, Bernaudin M, Roussel S, Petit E (2009). MRI assessment of hemodynamic effects of an angiopoietin-2 overexpression on a brain tumor model. Neuro Oncol. 11: 488-502
  60. Valable S, Francony G, Bouzat P, Fevre MC, Mahious N, Bouet V, Farion R, Barbier E, Lahrech H, Remy C, Petit E, Segebarth C, Bernaudin M, Payen JF (2009).The impact of erythropoietin on short-term changes in phosphorylation of brain protein kinases in a rat model of traumatic brain injury. J Cereb Blood Flow Metab. In press
  61. Viard A, Lebreton K, Chételat G, Desgranges B, Landeau B, Young A, de la Sayette V, Eustache F, Piolino P (2009). Patterns of hippocampal-neocortical interactions in the retrieval of episodic autobiographical memories across the entire life-span of aged adults. Hippocampus. In press
  62. Vivien D, Gauberti M, Guedin P, Anglés-Cano E, Strokavenir (2009). How to neutralize the neurotoxic effects of tPA. Med Sci (Paris). 25(10): 855-857
  63. Wong A C N, Jobard G, James K H, James T W, Gauthier I (2009). Expertise with characters in alphabetic and nonalphabetic writing systems engage overlapping occipito-temporal areas. Cogn Neuropsychol. 26: 111-127
  64. Yaouhi K, Bertran F, Clochon P, Mézenge F, Denise P, Foret J, Eustache F, Desgranges B(2009). A combined neuropsychological and brain imaging study of obstructive sleep apnea. J Sleep Res. 18(1): 36-48
  65. Yepes M, Roussel B, Ali C, Vivien D (2009). Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic. Trends Neurosci. 32: 48-55
Archives : 2009 - 2008 - 2007 - 2006